NCT06006247: An ongoing trial by Cerevance Beta, Inc.
This trial is ongoing. It must report results 7 months, 3 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06006247 |
|---|---|
| Title | A Randomized, Double-Blind, Placebo-Controlled Trial of CVN424 in Early Parkinson's Disease |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Sept. 11, 2023 |
| Completion date | Jan. 30, 2025 |
| Required reporting date | Jan. 30, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | June 6, 2025 |
| Days late | None |